earli
observ
anim
infect
viru
acquir
resist
coinfect
anoth
viru
observ
term
viral
interfer
solubl
factor
innat
antivir
activ
later
discov
name
interferon
ifn
subsequ
factor
identifi
belong
group
protein
current
type
ifn
known
type
ii
iii
distinct
structur
biolog
properti
activ
type
ifn
contain
major
subtyp
fibroblast
leukocyt
commonli
produc
nucleat
cell
expos
viral
infect
although
type
iii
ifn
ifn
also
produc
nucleat
cell
respons
infecti
viru
primarili
activ
epitheli
cell
unlik
type
ifn
receptor
broadli
produc
cell
type
type
iii
ifn
receptor
larg
restrict
cell
epitheli
origin
ifn
induc
express
numer
ifnstimul
gene
isg
involv
resist
viral
infect
myxoviru
resist
gene
also
belong
class
isg
origin
identifi
factor
confer
resist
lethal
influenza
viru
infect
mice
encod
interferoninduc
guanin
triphosphatas
gtpase
mxa
mxb
human
gene
express
strictli
control
virusinduc
type
type
iii
ifn
review
present
current
state
knowledg
structur
function
type
iii
ifn
receptor
addit
trace
cascad
reaction
switch
bind
ifn
receptor
lead
activ
structur
function
aspect
molecul
involv
describ
illustr
confid
level
antivir
mechan
understood
howev
overal
desir
distinguish
bacteri
infect
viral
develop
distinguish
tool
diagnost
purpos
decad
discoveri
ifn
gene
human
hu
clone
sequenc
sequenc
align
interferon
show
amino
acid
posit
compar
ident
ident
basi
sequenc
ident
conclud
gene
deriv
common
evolutionari
ancestor
soon
decod
sequenc
molecular
model
secondari
threedimension
structur
perform
basi
sequenc
predict
would
contain
stereochem
method
pack
globular
protein
segment
capabl
form
tightli
pack
hydrophob
core
local
thu
predict
globular
structur
name
ae
bundl
although
overal
ident
sequenc
sequenc
ab
loop
identit
conserv
amino
acid
residu
ab
loop
hydrophil
therefor
expos
surfac
also
ident
region
e
therefor
suggest
ab
loop
e
togeth
could
form
activ
site
later
sequenc
gene
differ
speci
compar
twentyon
conserv
posit
identifi
amino
acid
substitut
homolog
replac
cluster
conserv
posit
found
ab
loop
five
conserv
posit
compos
cluster
hydrophil
therefor
like
resid
surfac
molecul
second
cluster
conserv
posit
found
e
de
loop
predict
approach
found
mani
cytokin
macrophag
colonystimul
factor
granulocyt
colonystimul
factor
granulocytemacrophag
colonystimul
factor
chicken
myelomonocyt
growth
factor
relat
protein
contain
helic
segment
main
segment
capabl
form
tightli
pack
hydrophob
core
local
henc
ifn
fact
close
relat
famili
cytokin
present
type
ifn
compris
famili
member
subtyp
ifn
ifn
ifn
exhibit
approxim
sequenc
ident
despit
differenti
activ
type
ifn
initi
intracellular
signal
bind
common
receptor
compos
subunit
subunit
low
affin
therefor
get
high
affin
tripl
mutant
design
design
yn
stabl
crystal
structur
type
ifn
ternari
signal
complex
contain
receptor
chain
complex
yn
solv
crystallograph
analysi
confirm
structur
bundl
major
compos
bundl
label
ae
shown
fig
arrow
indic
direct
correspond
nto
cterminu
bind
oppos
surfac
molecul
fig
highaffin
bind
site
molecul
mostli
compos
ab
loop
e
fig
c
yn
correspond
huifn
import
residu
bind
huifnto
ligand
form
network
hydrogen
bond
main
chain
carbonyl
oxygen
atom
side
chain
replac
ala
yn
destabil
bind
mutat
previou
attent
drawn
equival
huifn
conserv
type
ifn
crystal
structur
ternari
complex
amino
acid
bind
similar
hydrophob
cluster
therefor
suggest
residu
energet
critic
share
anchor
point
mediat
ifn
crossreact
e
compris
side
chain
particip
bind
bind
site
molecul
form
b
c
fig
b
relat
class
ii
receptor
cytokin
intracellular
domain
associ
janu
kinas
jak
respect
type
ifn
bind
ifnar
chain
format
extracellular
signal
complex
jak
initi
phosphoryl
cascad
novel
type
ifn
name
type
iii
independ
discov
research
group
ifn
name
color
blue
b
c
helic
form
bind
site
side
chain
residu
contribut
bind
shown
front
b
project
color
red
e
helic
ab
loop
form
bind
site
side
chain
residu
contribut
bind
shown
front
c
project
figur
reconstruct
basi
amino
acid
sequenc
secondari
structur
coordin
atom
protein
data
bank
access
code
ternari
complex
owe
share
featur
type
ifn
member
famili
crystal
structur
identifi
level
evid
obtain
type
iii
ifn
initi
signal
bind
common
receptor
compos
fig
furthermor
crystal
structur
complex
highaffin
receptor
extracellular
domain
also
determin
basic
structur
bundl
element
c
e
f
cite
paper
mark
fig
b
c
e
facilit
comparison
type
ifn
topolog
describ
upupdownupdown
motif
found
previous
type
ifn
model
contain
residu
fig
residu
model
owe
poor
electron
densiti
probabl
due
flexibl
cd
loop
de
loop
similar
correspond
loop
type
ifn
long
ab
loop
element
b
cite
paper
helix
b
c
although
helix
link
nterminu
e
disulfid
bond
flexibl
solut
cy
residu
cy
residu
form
intramolecular
disulfid
bond
wherea
free
solut
intramolecular
disulfid
bond
first
disulfid
bond
connect
nterminu
end
c
second
disulfid
bond
connect
ab
loop
begin
helix
e
third
disulfid
bond
form
small
loop
end
helix
e
sequenc
similar
type
ifn
famili
sequenc
similar
wherea
similar
respect
type
iii
ifn
signal
receptor
complex
fig
wherea
type
ifn
signal
receptor
complex
fig
although
sequenc
similar
type
ifn
famili
receptor
type
iii
ifn
share
receptor
chain
thu
closer
relationship
famili
type
ifn
nevertheless
bind
ifnwith
receptor
complex
induc
intracellular
signal
pathway
activ
type
ifn
receptor
fig
bind
type
iii
ifn
membraneassoci
type
iii
receptor
complex
respect
lead
cross
phosphoryl
jak
activ
jak
phosphoryl
signal
transduc
activ
transcript
induc
heterodimer
dimer
recruit
interferon
respons
factor
form
trimer
transcript
factor
complex
name
interferonstimul
gene
factor
migrat
nucleu
bind
interferonstimul
respons
element
thu
promot
transcript
isg
includ
repertoir
gene
induc
type
iii
ifn
essenti
induc
type
ifn
consequ
type
iii
ifn
display
mani
biolog
activitiesinclud
antivir
activityin
wide
varieti
target
cell
express
type
iii
ifn
gene
correspond
protein
induc
infect
mani
type
virus
process
also
appli
gene
induc
type
ifn
howev
unlik
type
ifn
receptor
produc
cell
type
type
iii
ifn
receptor
mostli
restrict
cell
epitheli
origin
gene
mous
myxoviru
resist
protein
identifi
clone
decad
ago
main
ifninduc
intracellular
restrict
factor
influenza
influenzalik
virus
mice
mx
homolog
human
serv
similar
function
express
strictli
control
type
iii
ifn
human
also
known
mxa
also
known
mxb
encod
close
link
gene
long
arm
chromosom
map
posit
opposit
ifnstimul
gene
mx
gene
gener
induc
directli
virus
express
constitut
contrast
express
strictli
depend
ifn
signal
although
virus
like
hiv
may
induc
mxa
without
ifn
type
gener
mx
gene
excel
marker
ifn
action
structur
human
mxa
protein
show
elong
architectur
ntermin
gtpase
g
domain
antiparallel
bundl
call
bundlesign
element
bse
antiparallel
bundl
call
stalk
fig
figur
redrawn
basi
amino
acid
sequenc
secondari
structur
coordin
atom
taken
pdb
access
code
binari
complex
globular
g
domain
compris
central
core
consist
surround
segment
link
stalk
compos
long
g
domain
bind
hydrolyz
guanosin
triphosph
gtp
locat
opposit
site
extend
stalk
mxa
monom
fig
connect
g
domain
stalk
form
bse
compos
deriv
flank
region
g
domain
ctermin
part
molecul
fold
back
ntermin
g
domain
fig
bse
thought
function
mediat
conform
coupl
g
domain
stalk
transmit
signal
stalk
g
domain
vice
versa
transfer
structur
chang
induc
gtp
bind
hydrolysi
stalk
mxa
molecul
flexibl
owe
hingelik
region
realtim
domain
dynam
mxa
studi
singlemolecul
fluoresc
reson
energi
transfer
gdomainbs
region
adopt
either
open
close
conform
nucleotideload
condit
wherea
open
conform
prefer
nucleotidefre
gdp
alf
bound
gdpbound
form
load
gtp
activ
rel
movement
domain
alter
conform
prefer
close
state
moreov
frequent
rel
movement
observ
occur
bse
stalk
via
hing
fig
suggest
mxa
molecul
within
helic
polym
could
collect
gener
stabl
torqu
random
cycl
gtp
hydrolysi
stalk
mediat
ring
format
assembl
molecul
zigzag
fashion
fig
cryotransmiss
electron
microscopi
show
g
domain
direct
outer
side
multimer
ring
wherea
stalk
direct
opposit
inner
side
fig
amino
acid
loop
residu
term
protrud
tip
stalk
fig
shown
black
mediat
membran
interact
viral
target
recognit
produc
character
panel
g
domain
mutant
found
residu
catalyt
center
mxa
nucleotid
essenti
g
domain
dimer
also
demonstr
gtp
bind
contribut
assembl
mxa
stabl
multim
associ
endoplasm
reticulum
membran
wherea
nucleotid
hydrolysi
facilit
dynam
redistribut
mxa
endoplasm
reticulum
viral
ribonucleoprotein
nucleocapsid
actual
target
mxa
action
align
human
mxa
mxb
amino
acid
sequenc
display
ident
structur
show
ident
fold
architectur
gtpase
main
differ
protein
observ
within
rel
unstructur
ntermin
sequenc
extend
bse
unstructur
loop
stalk
mxb
stalk
monom
contain
bundl
form
dimer
mxb
dimer
interfac
show
residu
form
interfac
differ
mxb
mxa
result
mxb
dimer
stabl
mxa
although
mxa
mxb
stalk
share
sequenc
ident
overal
structur
stalk
conform
similar
although
human
mx
protein
share
common
characterist
dimer
uniqu
explain
peculiar
antivir
profil
mxa
protein
import
antivir
factor
broad
activ
divers
rna
virus
particular
demonstr
mxa
protein
inhibit
multipl
neg
strand
rna
virus
influenza
viru
vesicular
stomat
viru
measl
viru
virus
belong
famili
bunyavirida
addit
found
mxatransfect
cell
protect
semliki
forest
viru
togaviru
singlestrand
rna
genom
posit
polar
wherea
protect
multipl
positivestrand
rna
viru
mengoviru
encephalomyocard
viru
belong
picornavirida
famili
stabli
transfect
vero
cell
produc
mxa
cell
use
test
antivir
activ
mxa
coxsackieviru
vero
cell
produc
mxa
yield
dramat
reduc
addit
product
cvb
protein
analyz
immunofluoresc
highli
restrict
comparison
control
cell
moreov
accumul
negativeand
positivestrand
rna
prevent
shown
situ
hybrid
revers
transcript
pcr
obtain
result
evid
demonstr
antivir
activ
mxa
indic
replic
inhibit
earli
step
vero
cell
produc
mxa
mxa
protein
also
manifest
antivir
activ
dna
virus
like
vaccinia
viru
vacv
monkey
pox
viru
african
swine
fever
viru
virus
mxa
target
unknown
recent
wellstudi
dna
virus
repres
poxvirida
famili
test
sensit
mxa
cell
line
induc
produc
inhibitori
concentr
mxa
show
antivaccinia
viru
activ
indic
either
lack
suscept
viru
exist
viral
factor
capabl
counteract
mxa
inhibit
determin
vacv
resist
mxa
due
virusencod
antimxa
activ
vacv
mxasensit
vesicular
stomat
viru
coinfect
shown
vacv
protect
vesicular
stomat
viru
mxa
inhibit
protein
level
result
extend
sever
addit
vacv
strain
cpxv
strain
thu
confirm
orthopoxvirus
block
mxa
action
overal
result
point
lack
suscept
poxvirida
mxa
antivir
activ
recent
natur
occur
allel
variat
code
influenza
restrict
factor
mxa
investig
found
nonsynonym
variat
gtpase
domain
caus
loss
antivir
enzymat
activ
addit
demonstr
amino
acid
substitut
disrupt
interfac
gtpase
domain
dimer
requir
stimul
gtp
hydrolysi
result
obtain
convincingli
show
natur
occur
mutat
human
gene
influenc
mxa
function
may
also
explain
individu
variat
influenza
viru
suscept
human
popul
addit
isoform
mxb
protein
discov
long
short
molecul
long
isoform
compris
nuclear
local
sequencelik
stretch
basic
amino
acid
residu
promot
protein
local
preferenti
nuclear
pore
translat
short
kda
mxb
form
start
altern
methionin
codon
posit
therefor
lack
nuclear
local
sequenc
local
cytoplasm
mxa
protein
resid
cytoplasm
inhibit
broad
set
virus
independ
replic
site
comparison
long
form
human
mxb
local
cytoplasm
side
nuclear
pore
via
nterminu
inhibit
import
hiv
type
preintegr
complex
nucleu
addit
evid
indic
nterminu
human
mxb
respons
bind
hiv
type
capsid
inform
obtain
crystal
structur
studi
mxa
fig
togeth
mutat
studi
led
proposit
antivir
mechan
depend
multimer
assembl
mx
protein
model
mx
form
tetram
higher
mx
concentr
oligomer
larg
mx
ring
fig
gtpase
domain
situat
outsid
ring
stalk
direct
inward
furthermor
mx
ring
interact
gtpase
domain
increas
gtpase
activ
ctermini
mx
protein
import
bind
viral
target
mode
assembl
oligomer
possibl
lead
multipl
mx
ring
wrap
around
viral
target
structur
arrang
repetit
nucleoprotein
capsid
protein
molecul
potenti
multipl
bond
mx
oligom
therefor
even
lowaffin
interact
could
result
highavid
bind
mx
ring
could
prevent
assembl
nucleoprotein
complex
viral
polymeras
therebi
suppress
viru
transcript
replic
fig
mx
ring
could
also
transloc
viral
nucleoprotein
capsid
protein
perinuclear
complex
gtpasedepend
manner
lead
degrad
howev
detail
molecular
mechan
mx
gtpase
inhibit
suscept
virus
need
elucid
accord
center
diseas
control
prevent
antibiot
resist
one
seriou
health
problem
face
us
approxim
antibiot
prescrib
primari
care
respiratori
tract
infect
infect
viral
caus
antibiot
useless
unlik
provid
clinic
benefit
patient
time
inappropri
therapi
use
antibiot
viral
infect
increas
risk
emerg
antibioticresist
bacteri
strain
may
world
health
assembl
endors
global
action
plan
tackl
antibiot
resist
one
main
action
plan
optim
use
antibiot
medicin
human
anim
health
assembl
declar
decis
prescrib
antibiot
rare
base
definit
diagnos
effect
rapid
lowcost
diagnost
tool
need
guid
optim
use
antibiot
human
anim
medicin
tool
easili
integr
clinic
pharmaci
veterinari
practic
evidencebas
prescrib
dispens
standard
care
import
mention
mxa
intracellular
protein
therefor
method
detect
reli
releas
mxa
protein
cell
mxa
detect
capillari
blood
characterist
conveni
pediatr
could
benefici
use
mxa
biomark
concentr
mxa
protein
peripher
blood
healthi
peopl
ngml
induc
h
infect
halflif
day
mxa
achiev
peak
concentr
h
remain
increas
presenc
increas
ifn
mxa
product
peripher
blood
patient
shown
clinic
sensit
specif
marker
viral
infect
viral
infect
increas
mxa
modestli
increas
creactiv
protein
crp
concentr
protein
marker
suitabl
bacteri
infect
concentr
mxa
protein
investig
healthi
young
children
young
children
symptom
respiratori
viru
infect
observ
prospect
cohort
blood
sampl
nasal
swab
taken
children
without
symptom
respiratori
infect
respect
test
elisa
respiratori
virus
nasal
swab
test
pcrbase
detect
respiratori
virus
detect
symptomat
children
symptomat
mileston
viral
infect
pathway
cell
suppress
mx
protein
shown
mxa
b
ring
assum
prevent
assembl
nucleoprotein
complex
viral
polymeras
therebi
suppress
viru
transcript
replic
figur
redrawn
basi
data
present
refer
blood
measur
children
confirm
viral
bacteri
infect
uninfect
control
infect
unknown
origin
two
monoclon
antibodi
use
studi
one
monoclon
antibodi
direct
ctermin
ntermin
part
mxa
antibodi
use
respect
detect
captur
antibodi
sandwichtyp
immunoassay
studi
show
mxa
valuabl
diagnost
marker
viral
infect
children
combin
marker
specif
bacteri
infect
mxa
could
improv
manag
children
sign
infect
prospect
singl
center
blind
observ
clinic
trial
conduct
beth
israel
deaco
medic
center
determin
accuraci
pointofcar
immunoassay
identifi
clinic
signific
immun
respons
viral
andor
bacteri
infect
throat
swab
blood
sampl
taken
children
age
year
febril
pharyng
studi
microbi
caus
sought
bacteri
cultur
pcr
serolog
blood
mxa
concentr
determin
potenti
pathogen
detect
patient
group
streptococcu
ga
alon
ga
virus
group
c
g
streptococci
alon
togeth
virus
virus
alon
case
enterovirus
rhinovirus
adenovirus
frequent
detect
virus
blood
mxa
concentr
higher
children
viral
median
iqr
gl
concomit
gasvir
gl
sole
ga
gl
infect
thu
detect
respiratori
virus
simultan
increas
blood
mxa
concentr
support
caus
role
virus
children
pharyng
recent
new
pointofcar
rapid
crpmxa
immunoassay
rp
diagnost
use
prospect
multicent
crosssect
studi
adult
children
febril
upper
respiratori
tract
infect
conduct
evalu
diagnost
accuraci
test
identifi
clinic
signific
bacteri
infect
host
respons
acut
pathogen
viral
infect
among
patient
classifi
bacteri
viral
neg
refer
standard
bacteri
detect
agreement
febridx
refer
standard
febridx
clinic
sensit
ci
clinic
specif
ci
posit
predict
valu
ci
neg
predict
valu
ci
viral
detect
agreement
clinic
sensit
ci
clinic
specif
ci
posit
predict
valu
ci
neg
predict
valu
ci
mrna
index
mxa
interferon
respons
gene
viperin
tripartit
motifcontain
protein
investig
nasal
swab
potenti
biomark
viral
respiratori
infect
children
addit
respiratori
virus
swab
detect
pcr
nasal
mxa
viperin
index
increas
symptomat
virusposit
children
nasal
viperin
index
found
robust
marker
viral
respiratori
tract
infect
clinic
sensit
clinic
specif
distinguish
children
symptomat
viru
infect
asymptomat
virusneg
children
clinic
studi
show
mxa
protein
select
increas
patient
viral
infect
potenti
greatli
enhanc
rapid
distinct
viral
bacteri
respiratori
infect
biomark
crp
procalcitonin
independ
may
identifi
clinic
signific
infect
therebi
reduc
risk
miss
clinic
signific
bacteri
infect
howev
biomark
lack
adequ
clinic
specif
differenti
viral
bacteri
infect
ultim
lead
antibiot
overtreat
viral
infect
moreov
perform
characterist
crp
marker
bacteri
infect
vari
consider
among
publish
studi
heavili
influenc
organ
system
involv
numer
comorbid
therefor
procalcitonin
gain
favor
specif
biomark
bacteri
infect
also
includ
diagnost
viral
infect
human
trigger
cascad
interferonmedi
signal
lead
product
mx
protein
mxa
mxb
clinic
studi
show
combin
interpret
mxa
either
crp
andor
procalcitonin
dramat
improv
clinic
sensit
clinic
specif
differenti
infecti
etiolog
exclud
inappropri
therapi
antibiot
viral
infect
author
contribut
author
confirm
contribut
intellectu
content
paper
met
follow
requir
signific
contribut
concept
design
acquisit
data
analysi
interpret
data
b
draft
revis
articl
intellectu
content
c
final
approv
publish
articl
agreement
account
aspect
articl
thu
ensur
question
relat
accuraci
integr
part
